Trial Profile
A prospective trial evaluated the efficacy of bevacizumab on severe brain edema produced by re-irradiation in brain tumour patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Brain cancer; Oedema
- Focus Therapeutic Use
- 29 Mar 2016 New trial record